Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
116TH CONGRESS
1ST SESSION H. R. 2582
To amend the Controlled Substances Act to require the Attorney General
to make procurement quotas for opioid analgesics publicly available,
and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
MAY 8, 2019
Mr. CICILLINE introduced the following bill; which was referred to the Com-
mittee on Energy and Commerce, and in addition to the Committee on
the Judiciary, for a period to be subsequently determined by the Speaker,
in each case for consideration of such provisions as fall within the juris-
diction of the committee concerned
A BILL
To amend the Controlled Substances Act to require the At-
torney General to make procurement quotas for opioid
analgesics publicly available, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Opioid Quota Open-
4
ness, Transparency, and Awareness Act of 2019’’ or the
5
‘‘Opioid QuOTA Act’’.
6
VerDate Sep 11 2014
05:26 May 14, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
\\ALPHA3\E\BILLS\H2582.IH
H2582
kjohnson on DSK79L0C42 with BILLS
2
•HR 2582 IH
SEC. 2. PUBLIC REPORTING OF PROCUREMENT QUOTAS
1
FOR OPIOID ANALGESICS.
2
(a) IN GENERAL.—Section 306 of the Controlled
3
Substances Act (21 U.S.C. 826) is amended by adding at
4
the end the following:
5
‘‘(j)(1) In this subsection, the term ‘opioid procure-
6
ment quota’ means a quota established by the Attorney
7
General for the quantity of opioid analgesics that a reg-
8
istered manufacturer may procure for purposes of manu-
9
facturing dosage forms or other substances.
10
‘‘(2) The Attorney General shall make publicly avail-
11
able, including through the Web site of the Drug Enforce-
12
ment Administration—
13
‘‘(A) the quantity of the opioid procurement
14
quota for each registered manufacturer for each
15
year;
16
‘‘(B) the quantity of opioid analgesics procured
17
by each registered manufacturer for each year; and
18
‘‘(C) except as provided under paragraph (3)—
19
‘‘(i) a copy of the form or other applica-
20
tion, including any attachments or exhibits,
21
submitted by each registered manufacturer re-
22
questing an opioid procurement quota; and
23
‘‘(ii) a copy of each year-end or annual re-
24
port relating to the procurement or use of
25
opioid analgesics submitted to the Attorney
26
VerDate Sep 11 2014
05:26 May 14, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
\\ALPHA3\E\BILLS\H2582.IH
H2582
kjohnson on DSK79L0C42 with BILLS
3
•HR 2582 IH
General by a registered manufacturer to whom
1
the Attorney General has issued an opioid pro-
2
curement quota.
3
‘‘(3) Upon a request by a registered manufacturer as-
4
serting that a document or information described in clause
5
(i) or (ii) of paragraph (2)(C) is exempt from disclosure
6
under section 552(b)(4) of title 5, United States Code, and
7
to the extent that the Attorney General determines that
8
the document or information is exempt from disclosure
9
under such section 552(b)(4), the document or informa-
10
tion may be excluded from public disclosure under para-
11
graph (2).’’.
12
(b) GAO REPORT.—The Comptroller General of the
13
United States shall submit to Congress a report that, for
14
the 1-year period beginning on the date of enactment of
15
this Act—
16
(1) details—
17
(A) the number of instances in which a
18
registered manufacturer made a request de-
19
scribed in section 306(j)(3) of the Controlled
20
Substances Act, as added by subsection (a),
21
with respect to a document or information; and
22
(B) the number of instances in which the
23
Attorney General determined such a document
24
or information was exempt from disclosure
25
VerDate Sep 11 2014
05:26 May 14, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
\\ALPHA3\E\BILLS\H2582.IH
H2582
kjohnson on DSK79L0C42 with BILLS
4
•HR 2582 IH
under section 552(b)(4) of title 5, United
1
States Code; and
2
(2) evaluates the extent of the independent
3
evaluation conducted by the Attorney General of re-
4
quests described in section 306(j)(3) of the Con-
5
trolled Substances Act.
6
Æ
VerDate Sep 11 2014
05:26 May 14, 2019
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
\\ALPHA3\E\BILLS\H2582.IH
H2582
kjohnson on DSK79L0C42 with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.